Vivo CapitalInvestor Details

Get alertedif Vivo Capital makes an investment
Vivo Capital
Country:
City:
United States
Palo Alto
Industry:Other
Detailed industries:investment management
Key people
Frank KungManaging Partner
Want to know when Vivo Capital invests in a new company?
Portfolio:
Clinipace Inc (2021: $50,000,000 raised)
Rayzebio Inc (2021: $108,000,000 raised)
Esco Lifesciences Group Ltd (2021: $200,000,000 raised)
Aerobiotix (2021: $25,000,000 raised)
Sera Prognostics Inc (2021: $100,000,000 raised)
Kira Pharmaceuticals (2021: $53,500,000 raised)
Elevation Oncology (2020: $65,000,000 raised)
Gracell Biotechnologies (2020: $100,000,000 raised)
Olema Oncology (2020: $85,000,000 raised)
Tranquis Therapeutics (2020: $30,000,000 raised)
Nanjing Legend Biotechnology Co Ltd (2020: $150,000,000 raised)
Genetron (2019: $71,000,000 raised)
Arcutis Biotherapeutics (2019: $95,000,000 raised)
Swift Health Systems (2019: $45,000,000 raised)
Passage Bio (2019: $110,000,000 raised)
Revolution Medicines Inc (2019: $100,000,000 raised)
Poseida Therapeutics Inc (2019: $142,000,000 raised)
Maculogix Inc (2019: $38,700,000 raised)
Passage Bio (2019: $115,500,000 raised)
Bolt Biotherapeutics Inc (2019: $54,000,000 raised)
Innocare (2019: $160,000,000 raised)
Terns Pharmaceuticals Inc (2018: $80,000,000 raised)
Immune-onc Therapeutics Inc (2018: $33,000,000 raised)
Airxpanders Inc (2018: $15,000,000 raised)
Tot Biopharm Company Ltd (2018: $102,000,000 raised)
Sinovac Biotech Ltd (2018: $86,730,000 raised)
Tricida Inc (2018: $222,300,000 raised)
Metacrine Inc (2018: $65,000,000 raised)
Mei Pharma (2018: $75,000,000 raised)
Crinetics Pharmaceuticals (2018: $63,500,000 raised)
Innocare (2018: $55,000,000 raised)
Tricida Inc (2017: $57,500,000 raised)
Amyris Inc (2017: $25,000,000 raised)
Homology Medicines Inc (2017: $83,500,000 raised)
Aadi Bioscience (2017: $23,000,000 raised)
Angiotech Pharmaceuticals (2017: Undisclosed raised)
Impel Neuropharma Inc (2016: $36,000,000 raised)
Biohaven Pharmaceutical Holding Company Ltd (2016: $80,000,000 raised)
Readcoor (2016: $23,000,000 raised)
Sentreheart Inc (2016: $35,000,000 raised)
Fortis Therapeutics (2016: $18,000,000 raised)
Tricida Inc (2016: $55,000,000 raised)
Kala Pharmaceuticals Inc (2016: $68,000,000 raised)
Outpost Medicine (2016: $41,000,000 raised)
Crinetics Pharmaceuticals (2015: $40,000,000 raised)
Akari Therapeutics (2015: $75,000,000 raised)
Aclaris Therapeutics Inc (2015: $40,000,000 raised)
Nexcida Therapeutics Inc (2015: $2,750,002 raised)
Regenxbio (2015: $70,500,000 raised)
Nabriva Therapeutics Ag (2015: $120,000,000 raised)
Ascendis Pharma A S (2014: $60,000,000 raised)
Coherus Biosciences Inc (2014: $55,000,000 raised)
Pronai Therapeutics Inc (2014: $59,500,000 raised)
Nora Therapeutics Inc (2014: $18,000,000 raised)
Coinvestors:
Orbimed
Lilly Asia Ventures
Ra Capital Management
Venrock
Boxer Capital Llc
Longitude Capital
Rock Springs Capital
5AM Ventures
Cormorant Asset Management
Decheng Capital
Versant Ventures
Aisling Capital
Alexandria Venture Investments
Deerfield Management
Frazier Healthcare Partners
Sibling Capital Ventures
Sofinnova Ventures
Venbio Partners
Venrock Healthcare Capital Partners
ARCH Venture Partners
Adams Street Partners
Cam Capital
Deerfield
Deerfield Management Company
Fidelity Management & Research Company
Foresite Capital
Janus Capital Management Llc
Limulus Venture Partners
New Enterprise Associates
New Leaf Venture Partners Llc
Novo A/S
Novo Holdings
OrbiMed Advisors
Osage University Partners
Perceptive Advisors Llc
Polaris Partners
Qiming Venture Partners Usa
Ra Capital
Sectoral Asset Management
Wellington Management Company
-aperture Venture Partners
Abci Investment Management Ltd
Access Biotechnology
Acuta Capital Partners
Advantech Capital Lp
Amherst Fund Llc
Amoon Fund
Amzak Health
Anthem
Aperture Venture Partners Llc
Apjohn Ventures Fund
Aplus Partners
Arrowmark Partners
Asahi Kasei Ventures
Avalon Ventures
Avoro Capital Advisors
Berwind Private Equity
Biotechnology Value Fund
Biotechnology Value Fund (bvf)
Blackrock Inc
Blue Ox Healthcare Partners
Boxer Capital Of Tavistock Group
Bregua Corp
Brookside Capital
Burrill & Company
Bvf Partners
CVF
Cadence Pharmaceuticals
Canaan Partners
Capital Midwest Fund
Casdin Capital
Cathay Capital
Cathay Venture
Caxton Alternative Management Lp
Ccb Capital
Celgene
Center Laboratories Group
Chengwei Capital
China Investment Corp
China Orient Asset Management (international) Holding Ltd
China Universal (cayman) Gp Ltd
Cicc Healthcare Investment Fund
Connecticut Innovations
Cormorant Capital
Correlation Ventures
Cowen And Company Llc
Driehaus Capital Management Llc
E Fund
Ecor1 Capital
Fidelity Biosciences
Fidelity Management And Research Company
Fisk Ventures
Franklin Templeton Investments
Frazier Healthcare
Frazier Healthcare Ventures
Fung Shing Investments
Glsv
Goldman Sachs
Goldman Sachs J.p Morgan Securities Llc
Grand Angels
Gso Capital Partners Lp
Hansjorg Wyss
Hansjörg Wyss
Hbm
Hbm Healthcare Investments
Hermed Capital
Highline Capital Management
Hillsborough Venture
Hopen Life Science Ventures
Hudson Bay Capital
Incline Therapeutics Inc
Invus
J&j Development
Jianxin Capital
Kaiser Foundation Hospitals
King Star Med Lp
Kkr & Co
Knoll Capital Management
Koninklijke Dsm N.v
Lilly Ventures
Lily Asia Ventures
Limulus Venture Partner
Litmore Capital
Logos Capital
Loyal Valley Innovation Capital
Lux Capital
Malin Corp
Maverick Ventures
Morningside Ventures
Mossrock Capital Llc
NEA
Nan Fung Group
Nan Fung Life Sciences
Nextech Invest Ltd
Northern Light Venture Capital
Novartis
Novartis Ag
Novartis Venture Fund
Novo Holdings A/s
Omega Funds
Parian Global
Pentwater Capital Management Lp
Phase4 Partners
Pivotal Bioventure Partners
Pivotal Bioventures
Prospect Venture Partners
Prospect Ventures
Qiming Venture Partners
Quan Capital
Qvt Financial
Rapha Capital Management
Remiges Ventures
Rho Ventures
Roche Venture Fund
Rock Springs Capital Management
Samsara Biocapital
Schroder Adveq
Sequoia Capital China
Sphera Funds Management
Springhill Fund
Sr One Ltd
Superstring Capital
Tcg X
Temasek
Temasek Holdings Ltd
The Column Group
The Stanford-startx Fund
Third Rock Ventures Llc
U.s Venture Partners
Venbio
Vertex Ventures Hc
Vida Ventures
Wellcome Trust
Wellington Management
Wellington Management Company Llp
Yuanta Financial Holdings Group
Zq Capita
Zz Capital Co
This list displays investors that took part in the same funding round as Vivo Capital since March 2012. They are displayed in decreasing order of coinvesting frequency.
Please note that all data is automatically extracted and errors can occur.
The WhoGotFunded team has not necessarily reviewed the information in this page and has not determined if it is accurate and complete.
Inaccurate Data? Help us improve WhoGotFunded: post a comment!